by Patrick GALEY PARIS, France (AFP) — Limited global stocks of two anti-malarial drugs could wreck plans to use the medicines, currently in clinical trials, to treat COVID-19, doctors cautioned on Thursday. Around the world, countries are expanding access to chloroquine (CQ) and hydroxychloroquine (HCQ), which are used to treat malaria and are known to have anti-viral properties. The medicines have shown early promise against the COVID-19 illness in studies in France and China. CQ, […]